We are live on ! Find out more
SI

Sofinnova Investments Portfolio holdings

AUM $2.63B
1-Year Est. Return 117.41%
This Fund
S&P 500
This Quarter Est. Return
+35.89%
1 Year Est. Return
+117.41%
3 Year Est. Return
+428.82%
5 Year Est. Return
+748.21%
10 Year Est. Return
–
AUM
$1.8B
AUM Growth
+$7.91M
Cap. Flow
-$287M
Cap. Flow %
-15.97%
Top 10 Hldgs %
51.42%
Holding
93
New
31
Increased
19
Reduced
14
Closed
21

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$72.8M
2
INCY icon
Incyte
INCY
+$61.9M
3
IDXX icon
Idexx Laboratories
IDXX
+$41.1M
4
ARGX icon
argenx
ARGX
+$40.5M
5
PODD icon
Insulet
PODD
+$37.5M

Top Sells

Rank Stock Value
1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$437M
2
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$150M
3
IMGN
Immunogen Inc
IMGN
+$45.9M
4
LLY icon
Eli Lilly
LLY
+$37.6M
5
CYTK icon
Cytokinetics
CYTK
+$34.6M

Sector Composition

Rank Sector Weight
1 Healthcare 93.6%
2 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BOLT icon
51
Bolt Biotherapeutics
BOLT
$7.72M
$3.86M 0.21%
137,722
– –
FUSN
52
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$3.35M 0.19%
157,172
+31,873
+25% +$381K
MASI
53
DELISTED
Masimo
MASI
$2.94M 0.16%
20,000
+7,200
+56% +$930K
TFX icon
54
Teleflex
TFX
$5.94B
$2.75M 0.15%
+12,142
New +$2.88M
INSM icon
55
CALL
Insmed
INSM
$22.6B
$2.71M 0.15%
+100,000
New +$2.8M
COO icon
56
Cooper Companies
COO
$14.1B
$2.15M 0.12%
21,236
+5,236
+33% +$507K
INSP icon
57
Inspire Medical Systems
INSP
$1.5B
$1.74M 0.1%
+8,099
New +$1.59M
LIVN icon
58
LivaNova
LIVN
$4.51B
$1.14M 0.06%
+20,456
New +$1.06M
NCNA
59
NuCana
NCNA
$5.24M
$884K 0.05%
680
-257
-27% -$405K
AMLX icon
60
Amylyx Pharmaceuticals
AMLX
$2.17B
$871K 0.05%
+306,729
New +$4.01M
BAX icon
61
Baxter International
BAX
$12.6B
$855K 0.05%
+20,000
New +$813K
IMTXW
62
DELISTED
Immatics N.V. Warrants
IMTXW
$853K 0.05%
316,349
-2,023
-0.6% -$6.99K
AMLX icon
63
PUT
Amylyx Pharmaceuticals
AMLX
$2.17B
$852K 0.05%
+300,000
New +$3.92M
PDSB icon
64
PDS Biotechnology
PDSB
$38.6M
$565K 0.03%
142,635
– –
IMA
65
ImageneBio Inc
IMA
$64.6M
$543K 0.03%
31,885
+1,595
+5% +$29K
CATX icon
66
Perspective Therapeutics
CATX
$327M
$512K 0.03%
+43,011
New +$367K
NARI
67
DELISTED
Inari Medical, Inc. Common Stock
NARI
$490K 0.03%
+10,216
New +$546K
IRON icon
68
Disc Medicine
IRON
$2.85B
$384K 0.02%
+6,173
New +$400K
GPCR icon
69
Structure Therapeutics
GPCR
$3.4B
$374K 0.02%
8,733
-166,105
-95% -$7M
KYTX icon
70
Kyverna Therapeutics
KYTX
$455M
$248K 0.01%
+10,000
New +$279K
MIRM icon
71
Mirum Pharmaceuticals
MIRM
$6.84B
$75.7K ﹤0.01%
3,012
-349,385
-99% -$9.61M
AGEN
72
CALL
Agenus
AGEN
$274M
– –
-80,000
Closed -$1.32M
AGEN
73
Agenus
AGEN
$274M
– –
-782,812
Closed -$13M
CYTK icon
74
Cytokinetics
CYTK
$10.8B
– –
-414,207
Closed -$34.6M
DXCM icon
75
DexCom
DXCM
$28.9B
– –
-20,000
Closed -$2.48M
1 2
3
4

Similar funds

WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return
WCA
Waratah Capital Advisors Toronto, Ontario, Canada $2.63B AUM 76.33% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
NIG
NFJ Investment Group Dallas, Texas $2.64B AUM 23.86% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Sofinnova Investments's Q1 2024 Portfolio in Review

As of Q1 2024, Sofinnova Investments held 93 positions worth $1.8B, up 0.44% from $1.79B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Sofinnova Investments withdrew a net $287M in Q1 2024, closing 21 positions and reducing 14 holdings. Its most notable exit was Karuna Therapeutics, Inc. Common Stock, an estimated $437M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 97% a quarter earlier, followed by Consumer Staples.

Against the trend, Sofinnova Investments opened a new position in Novo Nordisk worth $78.6M.

  • Sofinnova Investments's largest Q1 2024 buy was Novo Nordisk: 611,884 shares worth $78.6M.
  • Sofinnova Investments added most to Incyte in Q1 2024, an estimated $61.9M increase.
  • Sofinnova Investments's biggest Q1 2024 reduction was IDEAYA Biosciences, cutting an estimated $29.1M.
  • Sofinnova Investments fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $437M.
  • Sofinnova Investments's ten largest holdings make up 51% of its $1.8B portfolio in Q1 2024.
  • Sofinnova Investments opened 31 new positions and closed 21 in Q1 2024.
  • Sofinnova Investments's portfolio value rose 0.44% quarter-over-quarter to $1.8B.

Based on Sofinnova Investments's 13F filing for Q1 2024, filed 15 May 2024.